Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-24-021045

CEO, CFO, Director acquired 666 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO, CFO, Director 2024-05-20 Grant or award +666 $4.97 $3,312 7,437 D: show line 1 in the form
Loading xslF345X05/ownership.xml…